Last Updated:
Searching
Create account to add to watchlist!

Clover Leaf Capital Corp. - CLOE

  • Commons

    $10.03

    +0.30%

    CLOE Vol: 1.8K

  • Units

    $10.45

    -0.48%

    CLOEU Vol: 0.0

Average: 0
Rating Count: 0
You Rated: Not rated

Please log in to rate.

SPAC Stats

Market Cap: 138.7M
Average Volume: 9.8K
52W Range: $9.85 - $10.65
Weekly %: +0.40%
Monthly %: +0.30%
Inst Owners: 1

Info

Target: Searching
Days Since IPO: 131
Unit composition:
Each unit has an offering price of $10.00 and consists of one share of our Class A common stock and one whole redeemable warrant
Trust Size: 12500000.0M

Management

Our officers, directors and director nominees are as follows: Name Age Position Felipe MacLean 37 Chairman of the Board, President and Chief Executive Officer Chris Rebentisch 38 Chief Operating Officer and Secretary Luis A. Guerra 46 Chief Financial Officer and Treasurer Per Bjorkman* 52 Director Nominee Marcos Angelini* 49 Director Nominee Ambassador Manuel Rocha* 70 Director Nominee ____________* This individual has indicated his assent to occupy such position on the effective date of the registration statement of which this prospectus is a part. Felipe MacLean, our President, CEO and Chairman of the Board, is a successful self-made entrepreneur with over 15 years of experience capitalizing on complex, high-yield transactions in various industries across the globe. Mr. MacLean applied his financial and operational expertise in building vertically integrated businesses in the agriculture, seafood, and edible oil sectors. He is a founder and CEO of Yntegra Group, a family office and multi-service provider that specializes in high yield transactions that has managed over $1 billion in commodities trading activity and placement of over $100 million in private equity investments. In 2017, Mr. MacLean started his venture in the cannabis industry founding Solace Holdings and leading an investment of over $50 million. Solace Holdings is today one of the most renowned cultivation, extraction and manufacturing facilities in the Nevada market, with leading product categories on its portfolio and doubling sales year over year. Mr. MacLean’s involvement was crucial for Solace Holdings success, supported by his clear understanding of the cannabis industry opportunities and challenges. We believe Mr. MacLean is well qualified to serve as our CEO due to his extensive knowledge in the cannabis industry, as an early investor in the field, he has lived through the multiple regulatory cycles and growth facets of this developing industry. His experience has proven instrumental in creating a successful large-scale profitable cannabis operation. Chris Rebentisch, our COO, has been responsible for Business Development for Spectrum Leaf Latam, LLC since December 2020, an innovative house of CBD wellness brands for the US and Latin American markets. Previously, he was the founder and creator of Canna Hemp™ and the President and CEO of 1933 Industries (TGIFF), Canna Hemp™’s parent company from June 2018 to June 2020. Mr. Rebentisch founded Infused Mfg LLC in August of 2016 and launched the Canna Hemp™ brand in June 2017, after personally developing and crafting each product with the belief in the natural healing properties of cannabis. Mr. Rebentisch is a seasoned cultivator and advocate for the industry in the State of Nevada. He began cultivating medical cannabis in April 2011 as a state licensed caregiver until April 2016, when Mr. Rebentisch turned his focus to hemp. Mr. Rebentisch’s depth of knowledge and expertise has made him a respected influencer in the field, where he is often invited to speak to academia and health care professionals about the viable applications of cannabis pharmacology as it applies to pain management and rehabilitation. We believe Mr. Rebentisch is well qualified to serve as our COO due to his extensive knowledge as a hands-on cannabis entrepreneur, in addition to being a recognized expert in cannabis. He brings valuable input and in-depth knowledge of all the verticals in the cannabis business. Luis A. Guerra, our CFO, was one of the founders of Bulltick Capital Markets, a regional investment bank in the US, Europe and Latin America which became one of the top 10 brokers and trading firms with the highest volume traded in Latin America ADRs (American Depositary Receipts) on the NYSE. He was a co-managing partner of the firm and member of its Management Committee, directly responsible for all securities brokerage, electronic trading, and capital markets operations from March 2000 to February 2011. He grew the firm’s brokerage and trading operations from a start-up to one of the largest regional investment banks in Latin America. Since November 2018, Mr. Guerra has served as co-founder and Managing Director of Vitax Partners, a private investment vehicle with a focus on private equity and structured finance. Since December 2019, he has also served as part of the Advisory Board of Welz, a European based private equity real estate Investment Manager, where he advises on their investment portfolio. He is a seasoned capital markets professional that brings experienced and structured financial reporting. We believe Mr. Guerra is well qualified to serve as our CFO due to his capital markets and financial background, he has ample experience dealing with regulated entities both in the US and internationally, in addition to his knowledge as a former senior executive at an investment bank and asset management business. 123 Table of Contents Per Bjorkman, will be one of our Independent Directors upon the effective date of this offering. Since August 2020, he has served as Director of Business Development at SHL Healthcare, one of the world’s leading contract manufacturers and suppliers of MedTech solutions for home, hospital and long-term care use. As a customer-centric company, SHL offers a range of services, robust manufacturing capabilities and dedicated project management teams to best translate customer specifications into quality products. Prior to this role, he served as Managing Director of SHL Technologies & Group Ventures from January 2014 to December 2019. Mr. Bjorkman is a seasoned expert in the cannabis and healthcare industry. From October 2017 to July 2020, he served as Co-CEO of Solace Holdings in Nevada, a cGMP certified, vertically integrated THC and CBD cannabis company, focusing on the cultivation and manufacturing of leading cannabis consumer branded goods. Mr. Bjorkman holds a bachelor’s degree in Business Administration from the European University and was part of the Leadership and Strategic Execution Program at INSEAD in France. We believe Mr. Bjorkman is well qualified to serve as a director due to his extensive knowledge in the mainstream medical and pharmaceutical industry, and its potential application to the cannabis field, in addition to having managed a successful cannabis growing and production facility in the US. Marcos Angelini, will be one of our Independent Directors upon the effective date of this offering. He currently serves as the President of Red Bull Latin America since April 2017. Since April 2019, Mr. Angelini has been a loan investor in Rubicon Organics and is currently in the process of becoming an advisor. Since August 2020, he started as an equity investor and is a member of the advisory board to YVY Brazil. Prior to these roles, from May 2016 to February 2017, Mr. Angelini was the CEO of Facebook in Brazil, where he oversaw the media giant operations in the largest country in Latin America. Mr. Angelini has 24 years of international experience in marketing, innovation, media, advertising and general management. From January 1996 to March 2016, he worked at Unilever, initially in marketing, rising to Brand VP and later Vice President for Latin America. At Unilever, he had responsibility for numerous products for global client subsidiaries throughout the world. He was recognized by Meio & Mensagem as one of the top 10 Marketing Executives of 2015 and as one of the top 10 Media Executives of Brazil in 2016. Mr. Angelini received his MBA from the University of Durham and completed a Business Executive Program at Stanford University. We believe Mr. Angelini is well qualified to serve as a director due to his extensive experience working as a senior executive with internationally recognized brands such as Redbull and Facebook, and his ample consumer brands knowledge as a senior level global marketing manager at Unilever. Ambassador Manuel Rocha, will be one of our Independent Directors upon the effective date of this offering. Before moving to Miami in 2002, he spent well over two decades as a US diplomat. His last post was as US Ambassador to Bolivia from July 2000 to August 2002. His Foreign Service career included assignments in the Dominican Republic, Italy, Honduras, Argentina and Cuba. Importantly, he was also Director of Inter-American Affairs in the National Security Council at the White House. Making the transition to the private sector, he worked for two law firms, established his own business development company bringing business opportunities from China to the Western Hemisphere, worked for a private equity firm based in Argentina, and headed Corporate Affairs for Arcos Dorados, which owns most of the McDonald’s restaurants in Latin America. All of this before serving as President of BARRICK Gold’s subsidiary in the Dominican Republic from September 2012 to April 2018, which represented the largest foreign direct investment in the country exceeding 5 billion dollars. Since May 2018, he has served as the SVP for Global Corporate Affairs for XCOAL, one of the largest exporters of US origin coals for use in integrated steel mills, cement plants, and power plants throughout the world. He graduated cum laude from Yale University, earned a master’s degree in Public Administration from Harvard University and a Master’s in International Relations from Georgetown University. We believe Mr. Rocha is well qualified to serve as a director due to his ample resources and network as a senior level, former State Department official, in addition to his experience running a large multinational operation. He is an expert negotiator who will bring valuable input in a highly regulated industry like cannabis. Number and Terms of Office of Officers and Directors We will have four directors upon completion of this offering. Our board of directors will be divided into two classes with only one class of directors being elected in each year and each class (except for those directors appointed prior to our first annual meeting of stockholders) serving a two-year term. In accordance with Nasdaq corporate governance requirements, we are not required to hold an annual meeting until one year after our first fiscal year end following our listing on Nasdaq. The term of office of the first class of directors, consisting of Manuel Rocha and Marcos Angelini, will expire at our first annual meeting of stockholders. The term of office of the second class of directors, consisting of Felipe MacLean and Per Bjorkman, will expire at the second annual meeting of stockholders. 124 Table of Contents Our officers are appointed by the board of directors and serve at the discretion of the board of directors, rather than for specific terms of office. Our board of directors is authorized to appoint persons to the offices set forth in our bylaws as it deems appropriate. Our bylaws provide that our officers may consist of a Chairman of the Board, Chief Executive Officer, Chief Financial Officer, President, Vice Presidents, Secretary, Treasurer, Assistant Secretaries and such other offices as may be determined by the board of directors. Nasdaq listing standards require that a majority of our board of directors be independent. An “independent director” is defined generally as a person other than an officer or employee of the company or its subsidiaries or any other individual having a relationship which in the opinion of the company’s board of directors, would interfere with the director’s exercise of independent judgment in carrying out the responsibilities of a director. Our board of directors has determined that Messrs. Angelini, Bjorkman and Ambassador Rocha are “independent directors” as defined in the Nasdaq listing standards and applicable SEC rules. Our independent directors will have regularly scheduled meetings at which only independent directors are present. Officer and Director Compensation Other than disclosed herein, none of our officers has received any cash compensation for services rendered to us. Commencing on the date of this prospectus, we have agreed to pay an affiliate of our sponsor a total of $10,000 per month for office space, utilities and secretarial and administrative support. Upon completion of our initial business combination or our liquidation, we will cease paying these monthly fees. No compensation of any kind, including any finder’s fee, reimbursement, consulting fee or monies in respect of any payment of a loan, will be paid by us to our sponsor, officers and directors, or any affiliate of our sponsor or officers, prior to, or in connection with any services rendered in order to effectuate, the consummation of our initial business combination (regardless of the type of transaction that it is). However, these individuals will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. Our audit committee will review on a quarterly basis all payments that were made to our sponsor, officers or directors, or our or their affiliates. Any such payments prior to an initial business combination will be made using funds held outside the trust account. Other than quarterly audit committee review of such payments, we do not expect to have any additional controls in place governing our reimbursement payments to our directors and executive officers for their out-of-pocket expenses incurred in connection with identifying and consummating an initial business combination. After the completion of our initial business combination, directors or members of our management team who remain with us may be paid consulting or management fees from the combined company. All of these fees will be fully disclosed to stockholders, to the extent then known, in the tender offer materials or proxy solicitation materials furnished to our stockholders in connection with a proposed initial business combination. We have not established any limit on the amount of such fees that may be paid by the combined company to our directors or members of management. It is unlikely the amount of such compensation will be known at the time of the proposed initial business combination, because the directors of the post-combination business will be responsible for determining officer and director compensation. Any compensation to be paid to our officers will be determined, or recommended to the board of directors for determination, either by a compensation committee constituted solely by independent directors or by a majority of the independent directors on our board of directors. We do not intend to take any action to ensure that members of our management team maintain their positions with us after the consummation of our initial business combination, although it is possible that some or all of our officers and directors may negotiate employment or consulting arrangements to remain with us after our initial business combination. The existence or terms of any such employment or consulting arrangements to retain their positions with us may influence our management’s motivation in identifying or selecting a target business but we do not believe that the ability of our management to remain with us after the consummation of our initial business combination will be a determining factor in our decision to proceed with any potential business combination. We are not party to any agreements with our officers and directors that provide for benefits upon termination of employment. 125 Table of Contents Committees of the Board of Directors Our board of directors will have two standing committees: an audit committee and a compensation committee. Subject to phase-in rules and a limited exception, Nasdaq rules and Rule 10A-3 of the Exchange Act require that the audit committee of a listed company be comprised solely of independent directors, and Nasdaq rules require that the compensation committee of a listed company be comprised solely of independent directors. Audit Committee Prior to the consummation of this offering, we will establish an audit committee of the board of directors. Marcos Angelini, Manuel Rocha and Per Bjorkman will serve as members of our audit committee, and Marcos Angelini will chair the audit committee. Under the Nasdaq listing standards and applicable SEC rules, we are required to have at least three members of the audit committee, all of whom must be independent. Each of Marcos Angelini, Manuel Rocha, and Per Bjorkman meet the independent director standard under Nasdaq listing standards and under Rule 10-A-3(b)(1) of the Exchange Act. Each member of the audit committee is financially literate and our board of directors has determined that Marcos Angelini qualifies as an “audit committee financial expert” as defined in applicable SEC rules. We will adopt an audit committee charter, which will detail the principal functions of the audit committee, including: • the appointment, compensation, retention, replacement, and oversight of the work of the independent registered public accounting firm engaged by us; • pre-approving all audit and permitted non-audit services to be provided by the independent registered public accounting firm engaged by us, and establishing pre-approval policies and procedures; • setting clear hiring policies for employees or former employees of the independent registered public accounting firm, including but not limited to, as required by applicable laws and regulations; • setting clear policies for audit partner rotation in compliance with applicable laws and regulations; • obtaining and reviewing a report, at least annually, from the independent registered public accounting firm describing (i) the independent registered public accounting firm’s internal quality-control procedures, (ii) any material issues raised by the most recent internal quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental or professional authorities within the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues and (iii) all relationships between the independent registered public accounting firm and us to assess the independent registered public accounting firm’s independence; • reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such transaction; and • reviewing with management, the independent registered public accounting firm, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding our financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities. Compensation Committee Prior to the consummation of this offering, we will establish a compensation committee of the board of directors. Per Bjorkman, Marcos Angelini, and Manuel Rocha will serve as members of our compensation committee. Under the Nasdaq listing standards and applicable SEC rules, we are required to have at least two members of the compensation committee, all of whom must be independent. Per Bjorkman, Marcos Angelini, and Manuel Rocha are independent, and Per Bjorkman will chair the compensation committee. 126 Table of Contents We will adopt a compensation committee charter, which will detail the principal functions of the compensation committee, including: • reviewing and approving on an annual basis th

Holder Stats

1 0
% of Shares Held by All Insider 0.00%
% of Shares Held by Institutions 0.22%
% of Float Held by Institutions 0.22%
Number of Institutions Holding Shares 1

Institutional Holders

Reporting Date Hedge Fund Shares Held Market Value % of Portfolio Quarterly Change in Shares Ownership in Company
2021-11-16 Schonfeld Strategic Advisors LLC 36,954 $370,000 0.0% 0 0.204%
2021-11-16 Oaktree Capital Management LP 200,000 $2,000,000 0.0% 0 1.105%
2021-11-16 CVI Holdings LLC 600,000 $5,990,000 0.4% 0 3.314%
2021-11-15 Polar Asset Management Partners Inc. 1,000,000 $9,980,000 0.1% 0 5.524%
2021-11-15 Rivernorth Capital Management LLC 11,930 $120,000 0.0% 0 0.066%
2021-11-15 Marshall Wace LLP 669,200 $6,680,000 0.0% 0 3.697%
2021-11-15 Hudson Bay Capital Management LP 1,245,000 $12,430,000 0.2% 0 6.877%
2021-11-15 Highbridge Capital Management LLC 1,145,074 $11,430,000 0.3% 0 6.325%
2021-11-12 GABELLI & Co INVESTMENT ADVISERS INC. 45,600 $460,000 0.1% 0 0.252%
2021-11-12 Gabelli Funds LLC 54,400 $540,000 0.0% 0 0.301%
2021-11-12 Periscope Capital Inc. 75,000 $750,000 0.0% 0 0.414%
2021-11-12 Weiss Asset Management LP 499,872 $4,990,000 0.1% 0 2.761%
2021-11-10 MMCAP International Inc. SPC 1,000,000 $9,980,000 0.7% 0 5.525%
2021-11-09 ATW Spac Management LLC 1,200,000 $11,970,000 2.2% 0 6.629%
2021-10-28 Mizuho Securities USA LLC 806,077 $7,960,000 0.8% 0 4.453%

SEC Filings

Form Type Form Description Filing Date Document Link
10-Q QUARTERLY REPORT 2021-11-26 https://www.sec.gov/Archives/edgar/data/1849058/000121390021062036/f10q0921_cloverleaf.htm
NT 10-Q NT 10-Q 2021-11-16 https://www.sec.gov/Archives/edgar/data/1849058/000121390021060100/ea150865-nt10q_clover.htm
8-K CURRENT REPORT 2021-09-08 https://www.sec.gov/Archives/edgar/data/1849058/000121390021047067/ea147069-8k_cloverleaf.htm
10-Q QUARTERLY REPORT 2021-09-02 https://www.sec.gov/Archives/edgar/data/1849058/000121390021046443/f10q0621_cloverleaf.htm
10-Q QUARTERLY REPORT 2021-09-02 https://www.sec.gov/Archives/edgar/data/1849058/000121390021046439/f10q0321_cloverleaf.htm
SC 13D SCHEDULE 13D 2021-08-12 https://www.sec.gov/Archives/edgar/data/1849058/000121390021042127/ea145737-13dyntegra_clover.htm
SC 13G CLOVER LEAF CAPITAL CORP. 2021-08-05 https://www.sec.gov/Archives/edgar/data/1849058/000090266421003730/p21-1861sc13g.htm
4 2021-07-30 https://www.sec.gov/Archives/edgar/data/1849058/000121390021039584/xslF345X03/ownership.xml
4 2021-07-30 https://www.sec.gov/Archives/edgar/data/1849058/000121390021039582/xslF345X03/ownership.xml
8-K CURRENT REPORT 2021-07-28 https://www.sec.gov/Archives/edgar/data/1849058/000121390021039135/ea144903-8k_cloverleaf.htm
SC 13G 2021-07-27 https://www.sec.gov/Archives/edgar/data/1849058/000149315221017849/formsc13g.htm
SC 13G FORM SC 13G 2021-07-27 https://www.sec.gov/Archives/edgar/data/1849058/000106299321006741/formsc13g.htm
8-K CURRENT REPORT 2021-07-23 https://www.sec.gov/Archives/edgar/data/1849058/000121390021038372/ea144649-8k_cloverleaf.htm
4 OWNERSHIP DOCUMENT 2021-07-22 https://www.sec.gov/Archives/edgar/data/1849058/000121390021038125/xslF345X03/ownership.xml
4 OWNERSHIP DOCUMENT 2021-07-22 https://www.sec.gov/Archives/edgar/data/1849058/000121390021038124/xslF345X03/ownership.xml
424B4 PROSPECTUS 2021-07-21 https://www.sec.gov/Archives/edgar/data/1849058/000121390021037849/f424b40721_cloverleafcapital.htm
EFFECT 2021-07-19 https://www.sec.gov/Archives/edgar/data/1849058/999999999521002822/xslEFFECTX01/primary_doc.xml
3 2021-07-19 https://www.sec.gov/Archives/edgar/data/1849058/000121390021037576/xslF345X02/ownership.xml
3 2021-07-19 https://www.sec.gov/Archives/edgar/data/1849058/000121390021037575/xslF345X02/ownership.xml
3 2021-07-19 https://www.sec.gov/Archives/edgar/data/1849058/000121390021037574/xslF345X02/ownership.xml
3 2021-07-19 https://www.sec.gov/Archives/edgar/data/1849058/000121390021037573/xslF345X02/ownership.xml
3 2021-07-19 https://www.sec.gov/Archives/edgar/data/1849058/000121390021037572/xslF345X02/ownership.xml
3 2021-07-19 https://www.sec.gov/Archives/edgar/data/1849058/000121390021037571/xslF345X02/ownership.xml
3 2021-07-19 https://www.sec.gov/Archives/edgar/data/1849058/000121390021037570/xslF345X02/ownership.xml
CERT 2021-07-19 https://www.sec.gov/Archives/edgar/data/1849058/000135445721000812/8A_Cert_CLOE.pdf
8-A12B REGISTRATION OF CERTAIN CLASSES OF SECURITIES 2021-07-16 https://www.sec.gov/Archives/edgar/data/1849058/000121390021037270/ea144341-8a12b_clever.htm
CORRESP 2021-07-15 https://www.sec.gov/Archives/edgar/data/1849058/000121390021037087/filename1.htm
CORRESP 2021-07-15 https://www.sec.gov/Archives/edgar/data/1849058/000121390021037085/filename1.htm
S-1/A REGISTRATION STATEMENT 2021-07-12 https://www.sec.gov/Archives/edgar/data/1849058/000121390021036422/fs12021a3_cloverleafcap.htm
CORRESP 2021-07-09 https://www.sec.gov/Archives/edgar/data/1849058/000121390021036423/filename1.htm
CORRESP 2021-06-22 https://www.sec.gov/Archives/edgar/data/1849058/000121390021033598/filename1.htm
S-1/A REGISTRATION STATEMENT 2021-06-22 https://www.sec.gov/Archives/edgar/data/1849058/000121390021033597/fs12021a2_cloverleafcap.htm
UPLOAD 2021-06-17 https://www.sec.gov/Archives/edgar/data/1849058/000000000021007484/filename1.pdf
S-1/A REGISTRATION AGREEMENT 2021-06-07 https://www.sec.gov/Archives/edgar/data/1849058/000121390021031098/fs12021a1_cloverleafcap.htm
CORRESP 2021-06-04 https://www.sec.gov/Archives/edgar/data/1849058/000121390021031099/filename1.htm
UPLOAD 2021-05-04 https://www.sec.gov/Archives/edgar/data/1849058/000000000021005721/filename1.pdf
S-1 REGISTRATION STATEMENT 2021-04-07 https://www.sec.gov/Archives/edgar/data/1849058/000121390021020691/fs12021_cloverleafcap.htm